NCT00117351 2011-02-17VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesMillennium Pharmaceuticals, Inc.Phase 2 Terminated